Combined immunochemotherapy with reduced dose whole brain radiotherapy (WBRT) for newly diagnosed patients (pts) with primary CNS lymphoma (PCNSL)

被引：0
|
作者：
Shah, G
Lai, R
Yahalom, J
Correa, D
DeAngelis, L
Raizer, J
Schiff, D
LaRocco, R
Grant, B
Abrey, L
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] McMaster Univ, Hamilton, ON L8S 4L8, Canada
[3] Northwestern Univ, Chicago, IL 60611 USA
[4] Univ Virginia, Med Ctr, Charlottesville, VA 22903 USA
[5] Kentuckiana Canc Inst PLLC, Louisville, KY USA
[6] Univ Vermont, Burlington, VT 05405 USA
来源：
NEURO-ONCOLOGY | 2005年 / 7卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
340
引用
收藏
页码：368 / 368
页数：1
相关论文
共 50 条
  • [31] Outcome of patients with newly diagnosed primary CNS lymphoma after high-dose methotrexate followed by consolidation whole-brain radiotherapy and cytarabine: an 8-year cohort study
    Pokpong Piriyakhuntorn
    Thanawat Rattanathammethee
    Sasinee Hantrakool
    Chatree Chai-Adisaksopha
    Ekarat Rattarittamrong
    Adisak Tantiworawit
    Lalita Norasetthada
    International Journal of Clinical Oncology, 2021, 26 : 1805 - 1811
  • [32] PRIMARY CNS LYMPHOMA (PCNSL): A RETROSPECTIVE ANALYSIS OF PATIENTS TREATED WITH PALLIATIVE RADIOTHERAPY (RT)
    Buglione, M.
    Borghetti, P.
    Trevisan, F.
    Maddalo, M.
    Bonetti, B.
    Bandera, L.
    Triggiani, L.
    Donadoni, L.
    Shehi, B.
    Magrini, S.
    RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S348 - S349
  • [33] RITUXIMAB AND MTX-BASED CHEMOTHERAPY FOLLOWED BY REDUCED WHOLE-BRAIN RADIATION (WBRT) IN UNTREATED PRIMARY CNS LYMPHOMA
    Oyama, Takashi
    Okamoto, Akinao
    Ikeda, Mika
    Suzuki, Tatsuya
    Kasai, Masanobu
    Uchida, Toshiki
    Mimura, Mikio
    Hatano, Norikazu
    Tsuzuki, Toyonori
    Ogura, Michinori
    ANNALS OF ONCOLOGY, 2010, 21 : 41 - 41
  • [34] How important is whole brain radiotherapy for treatment of primary CNS lymphoma?
    Cabanillas, Fernando
    LANCET ONCOLOGY, 2010, 11 (11): : 1011 - 1012
  • [35] Salvage whole brain radiotherapy for recurrent or refractory primary CNS lymphoma
    Hottinger, Andreas F.
    DeAngelis, Lisa M.
    Yahalom, Joachim
    Abrey, Lauren E.
    NEUROLOGY, 2007, 69 (11) : 1178 - 1182
  • [36] High dose thiotepa, busulfan, cyclophosphamide (TBC) and autologous hematopoietic stem cell transplantation (ASCT) without whole brain radiotherapy (WBRT) for primary central nervous system lymphoma (PCNSL).
    Stewart, DA
    Forsyth, P
    Chaudhry, A
    Jeje, O
    Morris, D
    Savoie, L
    Brown, C
    Russell, JR
    BLOOD, 2004, 104 (11) : 261A - 261A
  • [37] TOXICITY AND OUTCOMES OF REDUCED-DOSE WHOLE BRAIN RADIOTHERAPY AS CONSOLIDATION TREATMENT FOR PATIENTS WITH CNS LYMPHOMA IN REAL LIFE SETTING
    Lesueur, P.
    Damaj, G.
    Hoang-Xuan, K.
    Rolland, V.
    Schmitt, A.
    Chinot, O.
    Fabbro, M.
    Agape, P.
    Chabrot, C.
    Chebrek, S.
    Feuvret, L.
    Stefan, D.
    Soussain, C.
    Houillier, C.
    NEURO-ONCOLOGY, 2019, 21 : 84 - 85
  • [38] High-dose methotrexate and rituximab with deferred radiotherapy for newly diagnosed primary B-cell CNS lymphoma
    Chamberlain, Marc C.
    Johnston, Sandra K.
    NEURO-ONCOLOGY, 2010, 12 (07) : 736 - 744
  • [39] HIGH-DOSE MTX-BASED CHEMOTHERAPY FOR PRIMARY CNS LYMPHOMA: WITH OR WITHOUT WHOLE BRAIN RADIOTHERAPY? FINAL ANALYSIS OF G-PCNSL-SG-1
    Weller, Michael
    Thiel, Eckhard
    Martus, Peter
    Moehle, Robert
    Griesinger, Frank
    Rauch, Michael
    Roeth, Alexander
    Hertenstein, Bernd
    Fischer, Thomas
    Hundsberger, Thomas
    Mergenthaler, Hans-Guenter
    Junghanss, Christian
    Birnbaum, Tobias
    Fischer, Lars
    Jahnke, Kristoph
    Herrlinger, Ulrich
    Pietsch, Torsten
    Roth, Patrick
    Bamberg, Michael
    Korfel, Agnieszka
    NEURO-ONCOLOGY, 2014, 16
  • [40] Randomized phase III study of high-dose methotrexate and whole-brain radiotherapy with/without temozolomide for newly diagnosed primary CNS lymphoma: JCOG1114C
    Mishima, Kazuhiko
    Nishikawa, Ryo
    Narita, Yoshitaka
    Mizusawa, Junki
    Sumi, Minako
    Koga, Tomoyuki
    Sasaki, Nobuyoshi
    Kinoshita, Manabu
    Nagane, Motoo
    Arakawa, Yoshiki
    Yoshimoto, Koji
    Shibahara, Ichiyo
    Shinojima, Naoki
    Asano, Kenichiro
    Tsurubuchi, Takao
    Sasaki, Hikaru
    Asai, Akio
    Sasayama, Takashi
    Momii, Yasutomo
    Sasaki, Atsushi
    Nakamura, Shigeo
    Kojima, Masaru
    Tamaru, Junichi
    Tsuchiya, Kazuhiro
    Gomyo, Miho
    Abe, Kayoko
    Natsumeda, Manabu
    Yamasaki, Fumiyuki
    Katayama, Hiroshi
    Fukuda, Haruhiko
    NEURO-ONCOLOGY, 2023, 25 (04) : 687 - 698
12345